| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 7.6e-05 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 4.1e-05 | 1 |